Cargando…

Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial

BACKGROUND: Phobic anxiety disorders are among the most prevalent psychiatric disorders and are burdensome in terms of loss of quality of life and work productivity. Evidence-based treatments are relatively successful in the majority of patients, especially exposure therapy. However, a substantial s...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Flier, Febe E., Kwee, Caroline M. B., Cath, Danielle C., Batelaan, Neeltje M., Groenink, Lucianne, Duits, Puck, van der Veen, Date C., van Balkom, Anton J. L. M., Baas, Johanna M. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373100/ https://www.ncbi.nlm.nih.gov/pubmed/30760241 http://dx.doi.org/10.1186/s12888-019-2022-x

Ejemplares similares

Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool
por: Kwee, Caroline MB, et al.
Publicado: (2022)

High Current Anxiety Symptoms, But Not a Past Anxiety Disorder Diagnosis, are Associated with Impaired Fear Extinction
por: Duits, Puck, et al.
Publicado: (2016)

Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
por: Scholten, Willemijn, et al.
Publicado: (2020)

To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
por: Muntingh, Anna, et al.
Publicado: (2021)

Four-year course of quality of life and obsessive–compulsive disorder
por: Remmerswaal, Karin C. P., et al.
Publicado: (2019)

Anxiety sensitivity, its stability and longitudinal association with severity of anxiety symptoms
por: Hovenkamp-Hermelink, Johanna H. M., et al.
Publicado: (2019)

Does it blend? Exploring therapist fidelity in blended CBT for anxiety disorders
por: Romijn, Geke, et al.
Publicado: (2021)

Effects of tryptophan depletion on anxiety, a systematic review
por: Schopman, Simone M. E., et al.
Publicado: (2021)

Course trajectories of anxiety disorders: Results from a 6-year follow-up in a general population study
por: Schopman, Simone ME, et al.
Publicado: (2021)

Human Fear Acquisition Deficits in Relation to Genetic Variants of the Corticotropin Releasing Hormone Receptor 1 and the Serotonin Transporter
por: Heitland, Ivo, et al.
Publicado: (2013)

Prevention of anxiety disorders in primary care: A feasibility study
por: Batelaan, Neeltje M, et al.
Publicado: (2012)

Recurrence of anxiety disorders and its predictors in the general population
por: Scholten, Willemijn, et al.
Publicado: (2023)

Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials
por: Batelaan, Neeltje M, et al.
Publicado: (2017)

Barriers and facilitators for treatment-seeking in adults with a depressive or anxiety disorder in a Western-European health care setting: a qualitative study
por: Waumans, Ruth C., et al.
Publicado: (2022)

Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment: Meta-Analysis
por: Romijn, Geke, et al.
Publicado: (2019)

Facilitating factors and barriers in help-seeking behaviour in adolescents and young adults with depressive symptoms: A qualitative study
por: Eigenhuis, Eline, et al.
Publicado: (2021)

Predictors of Intensive Treatment in Patients With Obsessive-Compulsive Disorder
por: du Mortier, Johanna A. M., et al.
Publicado: (2021)

Anxiety, Mental Stress, and Sudden Cardiac Arrest: Epidemiology, Possible Mechanisms and Future Research
por: Batelaan, Neeltje M., et al.
Publicado: (2022)

Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up
por: Romijn, Geke, et al.
Publicado: (2021)

Patient preferences for a guided self-help programme to prevent relapse in anxiety or depression: A discrete choice experiment
por: Muntingh, Anna D. T., et al.
Publicado: (2019)

Nausea in Specific Phobia of Vomiting
por: Höller, Yvonne, et al.
Publicado: (2013)

Phobias
por: Emerson, Joyce
Publicado: (1968)

The GET READY relapse prevention programme for anxiety and depression: a mixed-methods study protocol
por: Krijnen-de Bruin, Esther, et al.
Publicado: (2019)

Usage Intensity of a Relapse Prevention Program and Its Relation to Symptom Severity in Remitted Patients With Anxiety and Depression: Pre-Post Study
por: Krijnen-de Bruin, Esther, et al.
Publicado: (2022)

Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review
por: Bokma, Wicher A., et al.
Publicado: (2019)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Vr exposure in cbt is effective and efficacious treatment for simple phobia (flight phobia)
por: D’Ambrosio, A., et al.
Publicado: (2021)

Predicting the naturalistic course in anxiety disorders using clinical and biological markers: a machine learning approach
por: Bokma, Wicher A., et al.
Publicado: (2022)

Fears and Phobias
por: Freeman, Hugh
Publicado: (1969)

EMDR for children with medically related subthreshold PTSD: short-term effects on PTSD, blood-injection-injury phobia, depression and sleep
por: Meentken, Maya G., et al.
Publicado: (2020)

5-HT(1A) receptor blockade reverses GABA(A) receptor α(3) subunit-mediated anxiolytic effects on stress-induced hyperthermia
por: Vinkers, Christiaan H., et al.
Publicado: (2010)

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
por: Garcia, Gabriel A., et al.
Publicado: (2022)

Phobias: their nature and control,
por: Rachman, Stanley
Publicado: (1968)

Truancy—Or School Phobia?
por: Ratcliffe, T. A.
Publicado: (1960)

Perceptions of free will in obsessive-compulsive disorder: a quantitative analysis
por: van Oudheusden, Lucas J. B., et al.
Publicado: (2018)

Biased emotional attention in patients with dental phobia
por: Alexopoulos, Johanna, et al.
Publicado: (2018)

Treatment of specific phobia in older adults
por: Pachana, Nancy A, et al.
Publicado: (2007)

The Effectiveness of Virtual Reality Exposure–Based Cognitive Behavioral Therapy for Severe Anxiety Disorders, Obsessive-Compulsive Disorder, and Posttraumatic Stress Disorder: Meta-analysis
por: van Loenen, Inge, et al.
Publicado: (2022)

Serotonin(1A) receptor deletion does not interact with maternal separation-induced increases in startle reactivity and prepulse inhibition deficits
por: Groenink, Lucianne, et al.
Publicado: (2010)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7oggvonc53a56669rm5vqn7vji